HOME >> MEDICINE >> NEWS
ELBW infants appear to be reaching functional outcomes as young adults similar to NBW infants

observed in employment/school status; 48 percent ELBW vs. 57 percent NBW young adults were permanently employed. No significant differences were found in the proportion living independently, married/cohabiting, or who were parents. The age of attainment of the above markers was similar for both groups. These findings hold even though participants with disabilities (27 percent ELBW vs. 2 percent NBW) were included.

"Against our expectations and many odds, a significant majority of ELBW young adults have overcome earlier difficulties to become functional members of society. It is not clear what factors contributed to the positive outcome beyond adolescence, as all through childhood the ELBW cohort was significantly compromised in comparison with their peers," the authors write. "Our study should provide hope to parents for an equivalent, if not a better, future for their premature children in the longer term. Ongoing studies from research centers with established cohorts from the recent era are warranted."


'"/>

Contact: Veronica McGuire
905-525-9140
JAMA and Archives Journals
7-Feb-2006


Page: 1 2

Related medicine news :

1. Baby DVDs, videos may hinder, not help, infants language development
2. MUHC-led international team identifies gene responsible for blindness in infants and children
3. HIV and malaria combine to adversely affect pregnant women and their infants
4. Small infants have greater survival rate in high level intensive care facilities
5. Breastfeeding duration rates for infants born in an inner-city WHO/UNICEF Baby-Friendly hospital
6. Resistant HIV quickly hides in infants cells
7. Family members most often source of whooping cough in young infants
8. Young infants should not be left unattended to sleep in car safety seats
9. Sildenafil prevents rebound pulmonary hypertension in infants
10. Low birth weight infants may have cognitive and physical problems when they reach adolescence
11. MRI scans in premature infants can predict future developmental delays

Post Your Comments:
(Date:7/7/2015)... ... July 07, 2015 , ... Dermatologists from the Mount ... (AIF), identifying 18 possible melanomas and 46 potential non-melanoma skin cancers (basal cell ... , The Aspen Ideas Festival, which was held from June 25 through July ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... is debuting their brand new website. The website’s goal is to provide patients ... selection of patient tools, including requesting appointments online. , Part of the center’s ...
(Date:7/7/2015)... ... ... The United States Centers for Disease Control and Prevention have awarded Fenway ... Coalition $3.78 million for a five-year HIV prevention partnership that will focus on ... the groups at highest risk of HIV infection in the US. Dubbed ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Quadrino Law Group ... Road, Suite 304, Melville, New York 11747. The new facility is a state ... and rail lines. , Richard Quadrino, the firm's CEO and founder, said, "We are ...
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... the leading global provider of advanced delivery technologies and development solutions for ... an exclusive licensing agreement with Excelimmune, Inc. to access its antibody combination ...
Breaking Medicine News(10 mins):Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2
(Date:7/7/2015)... 2015 Accelovance, Inc. (Accelovance), a global ... and General Medicine announced the completion of enrollment ... Heron Therapeutics, Inc. for the Phase 3 trial ... candidate SUSTOL® (granisetron injection, extended release) as part ... 1 receptor antagonist fosaprepitant and IV corticosteroid ...
(Date:7/7/2015)... 2015 Research and ... the "Deciphering Global Major Pharmaceutical Companies, New ... offering. It has been publicly recognized ... in a series of challenges in the recent ... significant overcapacities in small molecule product manufacturing; increasingly ...
(Date:7/7/2015)... 2015  PAREXEL International Corporation (NASDAQ: PRXL ) will ... 2015 on Wednesday, August 5 th , 2015 after the ... on PAREXEL,s website at www.PAREXEL.com and on the ... host a conference call and live webcast at 10:00 a.m. ... the results.  To access the webcast, visit PAREXEL,s website at ...
Breaking Medicine Technology:Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2
Cached News: